Zobrazeno 1 - 10
of 5 610
pro vyhledávání: '"dry‐powder inhaler"'
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 2415-2423 (2024)
Nicola Scichilone,1 Andrew Whittamore,2 Chris White,3 Elena Nudo,4 Massimo Savella,4 Marta Lombardini4 1Division of Respiratory Medicine, Department PROMISE, “Giaccone” University Hospital, University of Palermo, Palermo, Italy; 2Portsdown Group
Externí odkaz:
https://doaj.org/article/69fe7d65e2db442cb77d6ae8b54463ed
Autor:
Mas Fazlin Mohamad Jailaini, Jaya Muneswarao, Ching Zhen Hao, Rabia Hussain, Mohamed Faisal Abdul Hamid
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background: Dry powder inhalers (DPIs) are commonly used among patients with Chronic Obstructive Pulmonary Disease (COPD). These inhalers are breath-actuated, and require patients to generate sufficient peak inspiratory flow (PIF) to disaggregate the
Externí odkaz:
https://doaj.org/article/52569d6a6cfc4ecaad73b1c0beda00a0
Autor:
Bajwa EK, Cislak D, Kumar A, Li D, Messina EJ, Reynders T, Denef JF, Corcea V, Buch KP, Lai E, Stoch SA
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 1105-1121 (2024)
Ednan K Bajwa,1 Dawn Cislak,1 Amit Kumar,1 Dan Li,1 Eric J Messina,1 Tom Reynders,2 Jean-François Denef,2 Vasile Corcea,3 Ketan P Buch,4 Eseng Lai,1 S Aubrey Stoch1 1MRL, Merck & Co., Inc., Rahway, NJ, USA; 2Translational Medicine, MSD Belgium, Brus
Externí odkaz:
https://doaj.org/article/7886eda8508e426b928876250387faa7
Publikováno v:
Monaldi Archives for Chest Disease (2024)
Asthma is an obstructive lung disease with high prevalence. Symptom control in asthma remains poor despite significant advancements in treatment guidelines and inhalational devices. This is often attributed to inadequate patient adherence to the inha
Externí odkaz:
https://doaj.org/article/05743d39ae8d492faf384541031f864c
Autor:
Alison Tatiana Madrid Sani, Khellida Loiane V. Ramos-Rocha, Michelle Alvares Sarcinelli, Marcelo Henrique da Cunha Chaves, Helvécio Vinícius Antunes Rocha, Patrícia Léo, Natália Neto Pereira Cerize, Maria Helena Ambrosio Zanin, Valker Araujo Feitosa, Carlota de Oliveira Rangel-Yagui
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 27 (2024)
The COVID-19 pandemic has raised concern regarding respiratory system diseases and oral inhalation stands out as an attractive non-invasive route of administration for pulmonary diseases such as chronic bronchitis, cystic fibrosis, COVID-19 and commu
Externí odkaz:
https://doaj.org/article/3e81739cc5b74b1095bc1dba2338744d
Autor:
Eman Zmaily Dahmash, Nour Radwan Achkar, Dalia Khalil Ali, Qais Jarrar, Affiong Iyire, Shereen M. Assaf, Hamad Alyami
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Fixed dose combinations (FDCs) incorporating two or three medicines in a single inhaler have been created to enhance patient compliance and hence clinical outcomes. However, the development of dry powder inhalers (DPIs), particularly for FDC
Externí odkaz:
https://doaj.org/article/5650efc3d16e4e6188d24badecda72d0
Autor:
Chinmoyee Borah, Trideep Saikia, Alakesh Bharali, Madhuchandra Lahan, Nikhil Biswas, Bhanu P Sahu
Publikováno v:
Drugs and Drug Candidates, Vol 3, Iss 1, Pp 275-290 (2024)
Despite various efforts, a successful selective delivery system for chemotherapeutic agents for lung cancer is still lacking. Dry powder inhaler (DPI) systems based on proliposomes (PLMs) could be a potential system for the efficient delivery of pacl
Externí odkaz:
https://doaj.org/article/0338f858b7df4e908d12513604caa714
Publikováno v:
Pharmaceutics, Vol 16, Iss 11, p 1465 (2024)
Background: Cystic fibrosis is a hereditary disease, which causes the accumulation of dense mucus in the lungs accompanied by frequent local inflammation. The non-steroidal anti-inflammatory drug ibuprofen (IBU) and the mucolytic mannitol (MAN) can t
Externí odkaz:
https://doaj.org/article/697176eaea7f4e3a95422839025d9487
Publikováno v:
Pulmonary Therapy, Vol 10, Iss 1, Pp 109-122 (2024)
Abstract Introduction The selection of inhaler device is of critical importance in chronic obstructive pulmonary disease (COPD) as the interaction between a patient’s inhalation profile and the aerosol characteristics of an inhaler can affect drug
Externí odkaz:
https://doaj.org/article/832681727c5c44aeb48ec95bd5e0d15e
Autor:
Annette Kainu, Ville A. Vartiainen, Witold Mazur, Hanna Hisinger-Mölkänen, Federico Lavorini, Christer Janson, Martin Andersson
Publikováno v:
Pulmonary Therapy, Vol 10, Iss 1, Pp 133-142 (2024)
Abstract Introduction There is increasing pressure to use environmentally friendly dry powder inhalers (DPI) instead of pressurized metered-dose inhalers (pMDI). However, correct inhalation technique is needed for effective inhaler therapy, and there
Externí odkaz:
https://doaj.org/article/1d5a561385b849b58a84d7ae8635fc90